FREMONT, Calif. — Neuralink is pushing its brain-computer interface beyond the screen and into the physical world. The company has launched a new feasibility trial, the CONVOY study, that uses its N1 implant to control an investigational assistive robotic arm, a milestone that could one day let people with paralysis feed themselves, pick up objects, and perform everyday tasks using thought alone.
From Cursor to Robotic Limb
Until now, Neuralink participants have mostly used the implant to move a computer cursor, type, play video games, and even design 3D objects with computer-aided design software, all controlled directly by neural signals. CONVOY marks a major expansion of that capability, translating the same brain activity that moves a cursor into commands for a real robotic arm.
A participant identified as Alex became the first to enroll in the study, which explores using the Link to operate assistive devices such as an Assistive Robotic Arm. The implications are profound: an interface that began by restoring digital independence is now reaching toward restoring physical independence, the ability to interact with the tangible world. Neuralink described the broader progress of its participants on its official updates page.
Building on a Growing Trial Base
The robotic-arm work rests on a rapidly expanding clinical foundation. Neuralink has steadily increased its roster of implant recipients, recently reaching its 26th participant as trials extend across multiple countries. Each new participant adds data that sharpens the system's accuracy and broadens the range of tasks the implant can reliably control.
CONVOY also complements Neuralink's other frontier efforts. The company's VOICE trial aims to decode intended speech directly from brain activity, while a separate program targets vision restoration. Together, these studies sketch a future in which a single implant platform can restore communication, sight, and now physical manipulation, addressing several of the most life-altering consequences of neurological injury and disease.
Toward Everyday Independence
For people living with paralysis, the practical stakes of a thought-controlled robotic arm are enormous. Tasks that most people never think about, lifting a cup, handling utensils, moving an object from one place to another, can be transformative when restored. By proving that the N1 implant can drive an external robotic limb, Neuralink moves closer to delivering that kind of day-to-day autonomy.
The company has signaled that the technology will only get more capable. Elon Musk has described next-generation implants with dramatically higher electrode counts later in 2026, which would sharpen the resolution of neural signals and expand the precision of robotic control. Higher fidelity means smoother, more natural movement, the difference between a clumsy grab and a deliberate, controlled action.
CONVOY is still an early feasibility study, and Neuralink is careful to frame it as a research milestone rather than a finished product. But the direction is unmistakable. With participants already playing complex strategy games and designing in CAD by thought, and now reaching out through a robotic arm, Neuralink is steadily turning its bold promise, giving people back their independence, into demonstrable reality.
